Roche Holding AG
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Roche Holding AG
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
/ 
Roche Holding AG Genussscheine (ROG) are non-voting equity securities of Roche, a Swiss multinational healthcare group headquartered in Basel, Switzerland. Founded in 1896, Roche operates through two global divisions: Pharmaceuticals (innovative prescription medicines) and Diagnostics (in-vitro tests, instruments, and digital solutions for laboratories and healthcare providers).
Roche develops and supplies therapies and diagnostic technologies used worldwide across oncology, immunology, infectious diseases, neuroscience, and other therapeutic areas. Its Diagnostics businesses include solutions for clinical laboratories, point-of-care testing, tissue diagnostics, and molecular testing.
Roche Holding AG Genussscheine are listed on the SIX Swiss Exchange (SIX).
